€1.06
1.12% day before yesterday
Brüssel, Sep 12, 05:35 pm CET
ISIN
BE0974340722
Symbol
SEQUA

Sequana Medical Stock price

€1.06
-0.15 12.42% 1M
-0.43 28.75% 6M
-2.00 65.42% YTD
+0.11 11.37% 1Y
-4.64 81.44% 3Y
-5.04 82.66% 5Y
-7.36 87.43% 10Y
-7.36 87.43% 20Y
Brüssel, Closing price Fri, Sep 12 2025
-0.01 1.12%
ISIN
BE0974340722
Symbol
SEQUA

Key metrics

Basic
Market capitalization
€64.6m
Enterprise Value
€100.9m
Net debt
€36.3m
Cash
€3.8m
Shares outstanding
44.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
587.6 | 73.8
EV/Sales
917.6 | 115.3
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-446.3%
Return on Equity
100.6%
ROCE
42.1%
ROIC
379.7%
Debt/Equity
-0.9
Financials (TTM | estimate)
Revenue
€110.0k | €875.5k
EBITDA
€-17.6m | €-19.6m
EBIT
€-18.2m | €-21.2m
Net Income
€-44.7m | €-13.9m
Free Cash Flow
€-20.4m
Growth (TTM | estimate)
Revenue
-84.5% | 695.9%
EBITDA
37.6% | -11.1%
EBIT
36.9% | -16.5%
Net Income
-37.1% | 68.9%
Free Cash Flow
31.6%
Margin (TTM | estimate)
Gross
-3,067.1%
EBITDA
-16,689.9% | -2,235.3%
EBIT
-17,273.0%
Net
-42,325.7% | -1,585.9%
Free Cash Flow
-19,292.2%
More
EPS
€-1.2
FCF per Share
€-0.5
Short interest
-
Employees
48
Rev per Employee
€0.0
Show more

Is Sequana Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Sequana Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Sequana Medical forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Sequana Medical forecast:

Buy
80%
Hold
20%

Financial data from Sequana Medical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.11 0.11
85% 85%
100%
- Direct Costs 3.34 3.34
32% 32%
3,036%
-3.24 -3.24
22% 22%
-2,945%
- Selling and Administrative Expenses 7.37 7.37
16% 16%
6,700%
- Research and Development Expense - -
-
-
-18 -18
38% 38%
-16,009%
- Depreciation and Amortization 0.62 0.62
6% 6%
564%
EBIT (Operating Income) EBIT -18 -18
37% 37%
-16,566%
Net Profit -45 -45
37% 37%
-40,591%

In millions EUR.

Don't miss a Thing! We will send you all news about Sequana Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium.

Head office Belgium
CEO Ian Crosbie
Employees 48
Founded 2018
Website www.sequanamedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today